Challenges of equitable access to device-aided therapies for advanced Parkinson’s Disease in Poland — expert consensus and treatment recommendations
Consensus expert opinion is that APD patients in Poland would benefit from additional reimbursement access to these treatment options to improve APD patient care.
Authors
- Jarosław Sławek (ORCID: https://orcid.org/0000-0001-6816-0877)
- К. Ray Chaudhuri (ORCID: https://orcid.org/0000-0003-2815-0505)
- Karolina Popławska-Domaszewicz (ORCID: https://orcid.org/0000-0002-9154-389X)
- Monika Rudzińska (ORCID: https://orcid.org/0000-0002-1453-6856)
- Joanna Siuda (ORCID: https://orcid.org/0000-0002-0340-660X)
- Dariusz Koziorowski (ORCID: https://orcid.org/0000-0001-8920-8024)
- Sławomir Budrewićz (ORCID: https://orcid.org/0000-0002-2044-6347)
- Andrzej Bogucki (ORCID: https://orcid.org/0000-0002-1208-0912)
Institutions
- Poznan University of Medical Sciences (PL)
- Medical University of Silesia (PL)
- Medical University of Warsaw (PL)
- Wroclaw Medical University (PL)
- King's College Hospital NHS Foundation Trust (GB)
- Medical University of Lodz (PL)
- Andrzej Frycz Modrzewski Krakow University (PL)
- King's College Hospital (GB)
- Gdańsk Medical University (PL)
Publication Details
- Journal
- Neurologia i Neurochirurgia Polska
- Published
- 2024-12-27
- DOI
- https://doi.org/10.5603/pjnns.102680
- Citations
- 4
- Primary Topic
- Neurological disorders and treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.48
Funders
- Biogen
- Wellcome Trust
- Parkinson's Foundation
- National Institute for Health and Care Research
- Parkinson's UK
- EVER Neuro Pharma
- Wörwag Pharma
- Britannia Pharmaceuticals
- Medical Research Council